 WES MOORE, Governor  Ch. 753  
 
– 1 – Chapter 753  
(House Bill 127 ) 
 
AN ACT concerning  
 
Public Health – Nonoccupational Postexposure Prophylaxis (nPEP) Standing 
Order Program – Establishment  
 
FOR the purpose of establishing the Nonoccupational Postexposure Prophylaxis (nPEP) 
Standing Order Program to authorize pharmacists and health care providers  to 
prescribe or  dispense nPEP under certain circumstances; authorizing the Maryland 
Department of Health to administer the Program, collect fees necessary for the 
administration of the Program, and establish guidelines for training related to the 
Program; and generally relating to the Nonoccupational Postexposure Prophylaxis 
(nPEP) Standing Order Progr am. 
 
BY adding to  
 Article – Health – General  
Section 13 –5201 through 13–5205  13–5203  to be under the new subtitle “Subtitle 52. 
Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program”  
 Annotated Code of Maryland  
 (2023 Replacement Volume)  
 
BY repealing and reenacting, without amendments,  
 Article – Health Occupations  
 Section 12 –101(a)  
 Annotated Code of Maryland  
 (2021 Replacement Volume and 2023 Supplement)  
 
BY repealing and reenacting, with amendments,  
 Article – Health Occupatio ns 
 Section 12 –101(x)  
 Annotated Code of Maryland  
 (2021 Replacement Volume and 2023 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Health – General  
 
SUBTITLE 52. NONOCCUPAT IONAL POSTEXPOSURE PROPHYLAXIS  (NPEP)  
STANDING ORDER PROGRAM . 
 
13–5201.  
 
Ch. 753  2024 LAWS OF MARYLAND   
 
– 2 –  (A) IN THIS SUBTITLE THE FOLLOWING WORDS HAVE  THE MEANINGS 
INDICATED . 
 
 (B) “BOARD” MEANS THE STATE BOARD OF PHARMACY . 
 
 (C) “CDC  GUIDELINES ” MEANS THE “UPDATED GUIDELINES FOR 
ANTIRETROVIRAL POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL , INJECTION 
DRUG USE, OR OTHER NONOCCUPATIONAL EXPOSURE TO HIV  – UNITED STATES 
2016”  OR ANY SUBSEQUENT GU IDELINES PUBLISHED B Y THE CENTERS FOR 
DISEASE CONTROL AND PREVENTION .  
 
 (D) “NONOCCUPATIONAL POSTE XPOSURE PROPHYLAXIS ” OR “NPEP”  
MEANS MEDICATION USE D IN ACCORDANCE WITH  THE MOST RECENT  CDC  
GUIDELINES TO REDUCE THE CHANCES OF A PAT IENT DEVELOPING HIV  AFTER 
POTENTIAL EXPOSURE T O THE DISEASE . 
 
 (E) “PHARMACIST ” MEANS A PHARMACIST L ICENSED IN THE STATE UNDER 
TITLE 12 OF THE HEALTH OCCUPATIONS ARTICLE . 
 
 (F) “PRIVATE OR PUBLIC ENT ITY” MEANS A HEALTH CARE PROVIDER , 
LOCAL HEALTH DEPARTM ENT, COMMUNITY –BASED ORGANIZATION , OR OTHER  
PERSON THAT ADDRESSE S MED ICAL OR SOCIAL ISSUE S RELATED TO HIV  
EXPOSURE . 
 
 (G) (F) “PROGRAM ” MEANS THE NONOCCUPATIONAL POSTEXPOSURE 
PROPHYLAXIS  (NPEP)  STANDING ORDER PROGRAM . 
 
 (H) (G) “STANDING ORDER ” MEANS A DIRECTIVE AU THORIZING 
PHARMACISTS AND HEALTH CARE PROV IDERS  TO DISPENSE THE N PEP  REGIMENS 
LISTED IN THE ORDER WITHOUT A PRESCRIPTI ON. 
 
13–5202.  
 
 (A) THERE IS A NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS 
(NPEP)  STANDING ORDER PROGRAM . 
 
 (B) THE PROGRAM SHALL : 
 
  (1) AUTHORIZE A PHARMACIS T WHO IS REGISTERED WITH THE 
PROGRAM TO DISPENSE N PEP  THROUGH A STANDING O RDER IN ACCORDANCE 
WITH § 13–5203  OF THIS SUBTITLE ; AND 
 
 WES MOORE, Governor  Ch. 753  
 
– 3 –   (2) AUTHORIZE A LICENSED HEALTH CARE PROVIDER  WITH  
PRESCRIBING AUTHORIT Y TO PRESCRIBE AND D ISPENSE N PEP  THROUGH A  
STANDING ORDER IN AC CORDANCE WITH § 13–5204  OF THIS SUBTITLE ; AND  
 
  (3) OPERATE IN ACCORDANCE  WITH THE PROCEDURES APPROVED BY 
THE DEPARTMENT WITH THE A DVICE AND APPROVAL O F THE BOARD . 
 
 (C) THE DEPARTMENT SHALL ADOP T REGULATIONS NECESSARY : 
 
  (1) NECESSARY  FOR THE ADMINISTRATI ON OF THE PROGRAM ; AND 
 
  (2) THAT ADDRESS THE NEED S OF SPECIFIC POPULA TIONS 
INCLUDING VICTIMS OF  SEXUAL ASSAULT AND P EDIATRIC PATIENTS . 
 
 (D) THE DEPARTMENT MAY : 
 
  (1) COLLECT FEES NECESSAR Y FOR THE ADMINISTRA TION OF THE 
PROGRAM , UNLESS THE PATIENT Q UALIFIES FOR N PEP  THROUGH THE PROGRAM 
FOR PREVENTING HIV  INFECTION FOR RAPE VICTIMS ESTABLISHED U NDER §  
11–1008  OF THE CRIMINAL PROCEDURE ARTICLE ; 
 
  (2) ADMINISTER THE PROGRAM AND ESTABLISH  A STANDARDIZED 
SET OF GUIDELINES FO R PRIVATE AND PUBLIC E NTITIES  PHARMACISTS  
PARTICIPATING IN THE  PROGRAM TO USE IN DEV ELOPING AND CONDUCTI NG 
PATIENT EDUCATION AN D TRAINING ON N PEP  THAT INCLUDES : 
 
   (I) AVOIDING EXPOSURE TO HIV;  
 
   (II) RESPONDING TO EXPOSUR E TO HIV  WITH THE 
APPROPRIATE USE OF N PEP;  
 
   (III) ACCESS TO N PEP  AND T HE APPROPRIATE FOLLO W–UP 
AFTER THE ADMINISTRA TION OF N PEP;  AND 
 
   (IV) ENGAGEMENT IN ADDITIO NAL CARE INCLUDING : 
 
    1. ACCESS TO PRE –EXPOSURE PROPHYLAXIS  (PREP);  
AND 
 
    2. HARM REDUCTION PROGRA MS FOR PATIENTS WITH  
CONTINUING RISK OF E XPOSURES ; AND 
 
  (3) COLLECT AND REPORT DA TA ON THE OPERATION AND RESULTS 
OF THE PROGRAM . 
Ch. 753  2024 LAWS OF MARYLAND   
 
– 4 –  
13–5203.  
 
 (A) AT THE TIME OF DISPEN SING N PEP,  A PHARMACIST REGISTE RED WITH 
THE PROGRAM SHALL : 
 
  (1) SCREEN THE PATIENT TO  DETERMINE THAT HIV  EXPOSURE 
OCCURRED WITHIN 72 HOURS BEFORE  THE DISPENSING ; 
 
  (2) DETERMINE WHETHER THE  PATIENT MEETS CLINIC AL CRITERIA 
CONSISTENT WITH THE MOST RECENT  CDC  GUIDELINES , INCLUDING THE: 
 
   (I) THE IDENTIFICATION OF AN Y CONTRAINDICATED 
MEDICATIONS ; AND 
 
   (II) IF APPLICABLE , EXPOSURE AS THE RESU LT OF AN ALLEGED 
RAPE OR SEXUAL OFFEN SE OR ALLEGED CHILD SEXUAL ABUSE ; 
 
  (3) SUBJECT TO SUBSECTION  (B) OF THIS SECTION , DETERMINE 
WHETHER AN AVAILABLE  STANDING ORDER IS AP PROPRIATE FOR THE PA TIENT AND 
DISPENSE N PEP  IN ACCORDANCE WITH THE MOST RECENT  CDC  GUIDELINES ;  
 
  (4) REFER THE PATIENT TO A DISEASE INTERVENTI ON SPECIALIST 
WITHIN THE DEPARTMENT FOR ONGOIN G TREATMENT ; AND 
 
  (5) DETERMINE WHETHER THE  PATIENT HAS A PRIMAR Y CARE 
PROVIDER AND : 
 
   (I) IF THE PATIENT HAS A PRIMARY CARE PROVIDE R, NOTIFY 
THE PROVIDER THAT THE PA TIENT WAS DISPENSED NPEP;  OR 
 
   (II) IF THE PATIENT DOES N OT HAVE A PRIMARY CA RE 
PROVIDER , PROVIDE THE PATIENT WITH A LIST OF LOCAL  PRIMARY CARE 
PROVIDERS AND CLINIC S PROVIDED BY THE DEPARTMENT . 
 
 (B) IF AN AVAILABLE STAND ING ORDER IS NOT APPROPRIATE FOR THE 
PATIENT , THE PHARMACIST SHALL  REFER THE PATIENT TO  A PRIMARY CARE 
PROVIDER . 
 
 (C) A PHARMACIST MAY DISPE NSE N PEP  IN ACCORDANCE WITH A  THERAPY 
MANAGEMENT CONTRACT UNDER TITLE 12, SUBTITLE 6A OF THE HEALTH 
OCCUPATIONS ARTICLE . 
 
13–5204. 
 WES MOORE, Governor  Ch. 753  
 
– 5 –  
 (A) A LICENSED HEALTH CARE  PROVIDER WITH PRESCR IBING AUTHORITY  
WHO IS REGISTERED WI TH THE PROGRAM MAY DELEGATE THE DISPENSING OF  
NPEP  UNDER A STANDING ORD ER TO AN EMPLOYEE OR  A VOLUNTEER OF AN  
AUTHORIZED PRIVATE O R PUBLIC ENTITY IN A CCORDANCE WITH A WRITTEN  
AGREEMENT UNDER § 13–5205  OF THIS SUBTITLE . 
 
 (B) ANY LICENSED HEALTH C ARE PROVIDER WHO HAS  DISPENSING  
AUTHORITY MAY DISPEN SE N PEP  TO AN INDIVIDUAL IN ACCORDANCE WITH A  
STANDING ORDER IN AC CORDANCE WITH THIS S UBSECTION . 
 
13–5205.  
 
 AN AUTHORIZED PR IVATE OR PUBLIC ENTI TY SHALL ENTER INTO A WRITTEN  
AGREEMENT WITH A LIC ENSED HEALTH CARE PR OVIDER WITH PRESCRIB ING 
AUTHORITY TO ESTABLI SH PROTOCOLS FOR THE  PRESCRIBING AND DISP ENSING OF  
NPEP  TO ANY INDIVIDUAL IN  ACCORDANCE WITH THIS  SUBTITLE . 
 
Article – Health Occupations  
 
12–101. 
 
 (a) In this title the following words have the meanings indicated.  
 
 (x) (1) “Practice pharmacy” means to engage in any of the following activities:  
 
   (i) Providing pharmaceutical care;  
 
   (ii) Compounding, dispensing, or dis tributing prescription drugs or 
devices;  
 
   (iii) Compounding or dispensing nonprescription drugs or devices;  
 
   (iv) Monitoring prescriptions for prescription and nonprescription 
drugs or devices;  
 
   (v) Providing information, explanation, or recommend ations to 
patients and health care practitioners about the safe and effective use of prescription or 
nonprescription drugs or devices;  
 
   (vi) Identifying and appraising problems concerning the use or 
monitoring of therapy with drugs or devices;  
 
   (vii) Acting within the parameters of a therapy management contract, 
as provided under Subtitle 6A of this title;  
Ch. 753  2024 LAWS OF MARYLAND   
 
– 6 –  
   (viii)  Administering vaccinations in accordance with § 12 –508 of this 
title or self –administered drugs or maintenance injectable medications in  accordance with 
§ 12–509 of this title;  
 
   (ix) Delegating a pharmacy act to a registered pharmacy technician, 
pharmacy student, or an individual engaged in a Board approved pharmacy technician 
training program;  
 
   (x) Supervising a delegated pharmacy a ct performed by a registered 
pharmacy technician, pharmacy student, or an individual engaged in a Board approved 
pharmacy technician training program;  
 
   (xi) Providing drug therapy management in accordance with §  
19–713.6 of the Health – General Article ; 
 
   (xii) Prescribing and dispensing contraceptive medications and  
self–administered contraceptive devices approved by the U.S. Food and Drug 
Administration; [or] 
 
   (xiii)  Prescribing and dispensing nicotine replacement therapy 
medications ; OR 
 
   (XIV) IF THE PHARMACIST IS REGISTERED WITH THE 
NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS  (NPEP)  STANDING ORDER 
PROGRAM ESTABLISHED U NDER § 13–5202  OF THE HEALTH – GENERAL ARTICLE , 
PRESCRIBING AND  DISPENSING NONOCCUPA TIONAL POSTEXPOSURE PROPHYLAXIS 
(NPEP)  MEDICATION APPROVED BY  THE U.S.  FOOD AND DRUG ADMINISTRATION 
AND IN ACCORDANCE WI TH “UPDATED GUIDELINES FOR ANTIRETROVIRAL 
POSTEXPOSURE PROPHYLAXIS AFTER SEXUAL , INJECTION DRUG USE, OR OTHER 
NONOCCUPATIONAL EXPOSURE TO HIV  – UNITED STATES 2016”  OR SUBSEQUENT  
GUIDELINES PUBLISHED  BY THE FEDERAL CENTERS FOR DISEASE CONTROL AND 
PREVENTION . 
 
  (2) “Practice pharmacy” does not include the operations of a person who 
holds a permit issued under § 12 –6C–03 of this title.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That t his Act shall take effect 
October 1, 2024.  
 
Approved by the Governor, May 16, 2024.  